The Octanate® immune tolerance induction experience in haemophilia A patients with inhibitors and a poor prognosis:: prospective post-marketing study in progress

被引：0
|
作者：
Zozulya, N. I. . [1 ]
Plyushch, O. P. [1 ]
Severova, T. V. [1 ]
机构：
[1] Moscow Hemophilia Ctr, Moscow, Russia
来源：
HAEMOPHILIA | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：150 / 150
页数：1
相关论文
共 50 条
  • [21] Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis
    Batsuli, Glaivy
    Zimowski, Karen L.
    Tickle, Kelly
    Meeks, Shannon L.
    Sidonio, Robert F., Jr.
    HAEMOPHILIA, 2019, 25 (05) : 789 - 796
  • [22] Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors
    Astermark, J
    Morado, M
    Rocino, A
    Van den Berg, HM
    Von Depka, M
    Gringeri, A
    Mantovani, L
    Garrido, RP
    Schiavoni, M
    Villar, A
    Windyga, J
    HAEMOPHILIA, 2006, 12 (04) : 363 - 371
  • [23] A role for von Willebrand factor in immune tolerance induction in patients with haemophilia A and inhibitors?
    Di Minno, Giovanni
    Coppola, Antonio
    BLOOD TRANSFUSION, 2011, 9 : S14 - S20
  • [24] Immune tolerance induction in haemophilia A patients with high-responding inhibitors to factor VIII: experience at a single institution
    Rocino, A
    Papa, ML
    Salerno, E
    Capasso, F
    Miraglia, E
    De Biasi, R
    HAEMOPHILIA, 2001, 7 (01) : 33 - 38
  • [25] Prospective Study of the Immunological Mechanisms of Immune Tolerance Induction in Severe Haemophilia a Patients with Inhibitors: Preliminary Analysis of a Multi-Center Longitudinal Study
    Matino, Davide
    Castaman, Giancarlo
    Di Minno, Giovanni
    Giordano, Paola
    Mancuso, Maria Elisa
    Marchesini, Emanuela
    Peyvandi, Flora
    Santagostino, Elena
    Santoro, Cristina
    Schiavulli, Michele
    De Luca, Antonella
    Gargaro, Marco
    Puccetti, Paolo
    Fallarino, Francesca
    Iorio, Alfonso
    BLOOD, 2018, 132
  • [26] Immune tolerance for haemophilia patients with inhibitors: analysis of the western United States experience
    Damiano, ML
    Hutter, JJ
    HAEMOPHILIA, 2000, 6 (05) : 526 - 532
  • [27] First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study
    Kreuz, W.
    Ettingshausen, C. Escuriola
    Vdovin, V.
    Zozulya, N.
    Plyushch, O.
    Svirin, P.
    Andreeva, T.
    Bubanska, E.
    Campos, M.
    Benedik-Dolnicar, M.
    Jimenez-Yuste, V.
    Kitanovski, L.
    Klukowska, A.
    Momot, A.
    Osmulskaya, N.
    Prieto, M.
    Salek, S. Z.
    Velasco, F.
    Pavlova, A.
    Oldenburg, J.
    Knaub, S.
    Jansen, M.
    Belyanskaya, L.
    Walter, O.
    HAEMOPHILIA, 2016, 22 (01) : 87 - 95
  • [28] Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study)
    Rocino, A.
    Cortesi, P. A.
    Scalone, L.
    Mantovani, L. G.
    Crea, R.
    Gringeri, A.
    HAEMOPHILIA, 2016, 22 (01) : 96 - 102
  • [29] Immune tolerance induction in the era of emicizumab - still the first choice for patients with haemophilia A and inhibitors?
    Holstein, Katharina
    Le Quellec, Sandra
    Klamroth, Robert
    Batorova, Angelika
    Holme, Pal Andre
    Jimenez-Yuste, Victor
    Astermark, Jan
    HAEMOPHILIA, 2022, 28 (02) : 215 - 222
  • [30] Domain specificity of factor VIII inhibitors during immune tolerance induction in patients with haemophilia A
    van Helden, P. M. W.
    Kaijen, P. H. P.
    Mauser-Bunschoten, E. P.
    Fischer, K.
    van den Berg, H. M.
    Voorberg, J.
    HAEMOPHILIA, 2010, 16 (06) : 892 - 901
12345